Peptidyl-L-cysteine S-palmitoylation

pathway activity — cross-omics
GO:0018230Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Peptidyl-L-cysteine S-palmitoylation pathway is significantly associated with the RNA expression of multiple genes, with the LSCC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are LUM, CLMP, and ASPN, each associated with the pathway in up to 4 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Peptidyl-L-cysteine S-palmitoylation activity versus LUM in LSCC (Pearson r = -0.26).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LSCCLUM →-0.767-0.235.009.00134
LSCCCLMP →-0.693-0.206<.001<.00134
UCECASPN →-0.934-0.289.001.00533
UCECSELENOI →+0.483+0.222<.001.00533
UCECRNU6-647P →+1.343+0.226.002.00524
UCECSNORD65C →+1.402+0.239.003.00133
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0018230 vs LUM — LSCC

Per-sample scatter of Peptidyl-L-cysteine S-palmitoylation activity vs LUM in LSCC.

Explore this scatter interactively →

Exploration